BackOrganon Overview
Organon & Co.

Organon Target Price

Analysts' average 12-month price target for Organon is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.72

Average Target Price

$14.002% upside

1 analysts in the last 4 months

High: $14 | Low: $14

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-27Piper Sandler$142% upsideOpen
2026-04-10BNP Paribas$1212.5% downsideOpen
2026-02-24Barclays$841.7% downsideOpen
2025-12-08Barclays$7.545.3% downsideOpen
2025-10-27Piper SandlerDavid Amsellem$563.6% downsideOpen
2025-05-15Piper SandlerDavid Amsellem$1831.2% upsideOpen
2025-05-05Morgan StanleyTerence Flynn$1027.1% downsideOpen
2024-04-29Piper SandlerDavid Amsellem$2474.9% upsideOpen
2023-06-26Piper SandlerDavid Amsellem$34147.8% upsideOpen

Organon (OGN) FAQ

Organon posts a target price of $14. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $14 for OGN means covering analysts, on average, see the stock 2.0% upside of $13.72 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for OGN's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Organon's other metric pages and overview cover the third.

Judging Organon against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $14 here, then scan peer and history charts to see if the gap is persistent.